Early career · publishing since 2018Rising activity
Prostate Cancer Treatment and ResearchBone health and treatmentsCell Adhesion Molecules ResearchNeutrophil, Myeloperoxidase and Oxidative MechanismsPlatelet Disorders and Treatments
Publications
25
Citations
216
Est. group size
~3
Recurring co-author estimate
Active years
9
Publishing since 2018
In context
Among 1,353 early career Medicine PIs within our index
Citations: 216p25 74 · p75 317 · cohort median 157
Publications / year (recent): 4.4p25 1.8 · p75 4.4 · cohort median 2.6
Typically publishes in teams of ~13 · 7% small-team papers (≤3 authors) · across 4 venues
Publication cadence
Publications per year over the last 10 years — averaging 4.4/year recently
Recent publications
- Harnessing Targeted Polymerized Salicylic Acid Particles to Mitigate Neutrophil-Driven Inflammation
ACS Biomaterials Science & Engineering · 2026
- Targeted Deletion of Cxcl1 in MSCs Regulates Osteogenesis and Suppresses Bone-Metastatic Prostate Cancer
Molecular Cancer Research · 2025
- Table S1 from Targeted Deletion of Cxcl1 in MSCs Regulates Osteogenesis and Suppresses Bone-Metastatic Prostate Cancer
2025
- Figure S4 from Targeted Deletion of Cxcl1 in MSCs Regulates Osteogenesis and Suppresses Bone-Metastatic Prostate Cancer
2025
- Table S2 from Targeted Deletion of Cxcl1 in MSCs Regulates Osteogenesis and Suppresses Bone-Metastatic Prostate Cancer
2025
- Table S3 from Targeted Deletion of Cxcl1 in MSCs Regulates Osteogenesis and Suppresses Bone-Metastatic Prostate Cancer
2025
- Figure S7 from Targeted Deletion of Cxcl1 in MSCs Regulates Osteogenesis and Suppresses Bone-Metastatic Prostate Cancer
2025
- Figure S5 from Targeted Deletion of Cxcl1 in MSCs Regulates Osteogenesis and Suppresses Bone-Metastatic Prostate Cancer
2025
- Data from Targeted Deletion of Cxcl1 in MSCs Regulates Osteogenesis and Suppresses Bone-Metastatic Prostate Cancer
2025
- Figure S1 from Targeted Deletion of Cxcl1 in MSCs Regulates Osteogenesis and Suppresses Bone-Metastatic Prostate Cancer
2025
- Figure S3 from Targeted Deletion of Cxcl1 in MSCs Regulates Osteogenesis and Suppresses Bone-Metastatic Prostate Cancer
2025
- Figure S2 from Targeted Deletion of Cxcl1 in MSCs Regulates Osteogenesis and Suppresses Bone-Metastatic Prostate Cancer
2025
- Figure S6 from Targeted Deletion of Cxcl1 in MSCs Regulates Osteogenesis and Suppresses Bone-Metastatic Prostate Cancer
2025
- Leveraging Neutrophil-Particle Interactions to Develop Therapeutics for Acute Inflammatory Diseases
Deep Blue (University of Michigan) · 2024
- Identification of putative effectors of the Type IV secretion system from the Wolbachia endosymbiont of Brugia malayi
PLoS ONE · 2018
Publishes in
- Advanced Healthcare Materials×5
- Science Advances×2
- Nature Reviews Materials×1
- Nature Communications×1
- PLoS ONE×1
Similar researchers
By research-topic overlap
- Honglai Zhang
Medicine · University of Michigan
- Honglai Zhang
Medicine · University of Michigan
- Evan T. Keller
Medicine · University of Michigan
- Fabiana N. Soki
Medicine · University of Michigan
- Jill M. Keller
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile